Karolinska Development elects Rosenlew to board
This article was originally published in Scrip
Karolinska Development, the early stage biotech investment company linked to the Karolinska Institute, has elected Michael Rosenlew to its board. Mr Rosenlew was previously a managing partner and member of the executive committee of IK Investment Partners. Prior to that he held both financial and managerial positions in a number of Finnish companies, including the Amer Group.